At RSNA 2025, Mirai is changing breast cancer screening

Image credit: Aunt Minnie
If a picture is worth a thousand words, then in artificial intelligence, a picture can be worth millions of data points. AI’s superior ability to analyze images and large volume of imaging-based AI models is why many consider radiology to be among the medical fields most impacted by the rise of AI.
This was no less true at this year’s RSNA Annual Meeting (Nov. 30 – Dec. 4), the world’s largest radiology conference and one of the largest medical meetings overall, where Mirai was prominently featured.
Over the years, Mirai, a deep learning model for 5-year breast cancer risk prediction that was released in 2019, has been the subject of a number of validation studies conducted by clinicians who have been interested in the model’s potential to personalize breast cancer screening.
At this year’s RSNA meeting, validation research on Mirai was shared across nine different sessions in 11 presentations given by clinicians from hospitals across the U.S., marking shift the technology’s adoption that will hopefully only continue to grow.
Below are the 11 abstracts conducting additional validation research on Mirai in different contexts:
S3B-SPBR-7 LONGITUDINAL CHANGE OF MAMMOGRAPHIC AI RISK SCORES OVER REPEATED SCREENING EXAMS
